AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
Mexico Approves Immune System Enhancer.(SciClone Pharmaceuticals' Zadaxin approved)
2001 AUG 15 - (NewsRx.com & NewsRx.net) --
SciClone Pharmaceuticals (SCLN) announced that its immune system enhancer Zadaxin(R) has been approved for expanded indications in Mexico. Zadaxin may now be marketed for the treatment of hepatitis C and hepatitis B infection as well as for use as an influenza vaccine adjuvant.
The approval was based on existing clinical data from Zadaxin marketing registrations around the world. This marks its first approval for hepatitis in North America. Zadaxin currently is in a Phase III U.S. clinical program for hepatitis C infection, combining Zadaxin with pegylated alpha interferon.
"The hepatitis C and hepatitis B Zadaxin approvals in a neighboring country complements what we believe will be a growing awareness of our U.S. Phase III hepatitis C clinical program," said Donald R. Sellers, SciClone.
Zadaxin, a synthetic preparation of thymosin alpha 1, a peptide that occurs naturally in humans, and an immune system enhancer that helps stimulate, maintain, and direct the body's ...
- Update on pivotal phase III trial with MyVax Personalized Immunotherapy.
- Newspaper article from: Vaccine Weekly March 17, 2004 700+ words
...in November 2000, the phase III trial is designed to...goal of this pivotal phase III clinical trial is to...patients in our pivotal phase III trial of MyVax Personalized...article was prepared by Vaccine Weekly editors from staff and...
- Diamyd(R) Phase III Study Approved for Younger Patients in the US.
- Newspaper article from: Vaccine Weekly June 24, 2009 700+ words
...age in the company's Phase III study with the diabetes...conducting two parallel phase III studies, one in Europe...years of age in the US phase III study. "This is a big...article was prepared by Vaccine Weekly editors from staff and...
- Phase III study for kidney cancer vaccine analyzed.
- Newspaper article from: Vaccine Weekly January 21, 2004 700+ words
...interim analysis of a Phase III clinical trial of the...analysis of the randomized Phase III trial. The DMC declared...article was prepared by Vaccine Weekly editors from staff and...reports. Copyright 2004, Vaccine Weekly via NewsRx.com &...
- Significant survival advantage reported in phase III trial of Theratope.
- Newspaper article from: Vaccine Weekly July 7, 2004 700+ words
...Theratope vaccine as part of Biomira's phase III study of the vaccine in the treatment...breast cancer. Updated results from the phase III trial, including the exploratory analysis...we will be required to do a subsequent phase III study in order to move this product to...
- Prostate cancer vaccine on track for phase III clinical trials.
- Newspaper article from: Vaccine Weekly November 27, 2002 700+ words
...manufacturing facilities for phase III trials and market launch...is on track to enter phase III clinical trials by mid...expects to initiate a phase III clinical trial by mid...article was prepared by Vaccine Weekly editors from staff and...
- VaxGen's phase III trial in Thailand clears final scheduled safety review.
- Newspaper article from: Vaccine Weekly December 11, 2002 700+ words
...conduct review of the company's phase III trial in Thailand and once again...announced. VaxGen is conducting two phase III trials, one in Thailand and another...This article was prepared by Vaccine Weekly editors from staff and other reports...
- Neurocrine Biosciences Ramps Up Phase III Clinical Trials for NBI-34060 In...
- Press release article from: PR Newswire March 19, 2002 700+ words
...is initiating three additional pivotal Phase III clinical trials of NBI-34060 Immediate...1200 patients. The Company's first Phase III study with NBI-34060-IR was previously...currently be conducting four of eight planned Phase III clinical trials with NBI-34060. According...
- Phase III Medical Announces Appointment of Harvard's Dr. Wayne Marasco as...
- Press release article from: Business Wire November 23, 2004 700+ words
MELVILLE, N.Y. -- Phase III Medical, Inc. (OTCBB:PHSM...Marasco joined the Board of Directors of Phase III Medical in June 2003. He is an Associate...biographical information on Dr. Marasco and Phase III Medical, please refer to the Company...
Source: HighBeam Research, Mexico Approves Immune System Enhancer.(SciClone Pharmaceuticals'...